INTRODUCTION
Colony-stimulating factor (CSF)' is a proteini re(Iuiire(1 for the in vitro growth of grantilocyte and(I mlacrophage colonies from bone marrow (1) and has been postulalted to function as a granulopoietin in vivo. CSF is found widely distributed in many tissues and has been purified from several murine sources (2) (3) (4) (5) , humnan urine (6) , and human lung (7) . More recently. ill our constant search for practical souirces of human CSF, we discovered that a humani pancreatic careiniomiia cell line established in ouir laboratory (8) secretes relatively large amoun-its of CSF into the medium. Upon purification, two distinict CSF activities were found separable by isoelectrofocusing (9) , and different with respect to their isoelectric point (PI), molecular weight, and relative activity in imiouise vs. human bone marrow. This pattern had not been previously observed in our work with humani luniig CSF (7 Preparative isoelectrofocusing. Serum-free conditioned mediumii was concentrated bv Amicon ultrafiltration (PM10 membrane, Amiicon Corp., Lexington, Mass.) to 3.0 ml and dialyzed against distilled water overnight (three timnes). The sample was subjected to flat-bed preparative isoelectrofocusing accor(ling to procedures described previously (9 Morphology of colonies. Types I and II CSF from the different sources were used after the gel filtration step. Table I shows a summary of the morphology of colonies grown from mouse marrow in the presence of type I and from human marrow with type II CSF. Type I CSF predominantly yields colonies of macrophages, although most of the colonies grown in the presence of type II CSF are granulocytic.
DISCUSSION
The studies described herein were prompted by the finding of two distinct types of CSF in conditioned medium prepared from cultured human pancreatic carcinoma (MIA PaCa-2) (9): one high molecular weight CSF more active in mouse marrow and another, smaller molecular weight CSF active in human marrow. This finding had not been observed in our earlier work on human lung (7) . The results of our studies using isoelectrofocusing in the initial purification suggest that previously used purification procedures resulted in significant losses of type II or human active CSF. Furthermore, it was uncertain whether the activities in mouse and human marrow represented one or two separate molecular species of CSF. Our studies clearly demonstrate the presence in human tissues of two distinct types of CSF widely separable by isoelectrofocusing. Type I has mol wt 50,000, exhibits greater activity in mouse marrow, and yields predominantly macrophagic colonies. Type II CSF ha mol wt 27,000, is more active in human marrow, and yields mostly granulocytic colonies. The heterogeneity oftype I CSF on isoelectrofocusing has been shown to be the result of different content of sialic acid because treatment with neuraminidase reduces type I CSF to one peak with a PI of 4.7.
The nonequivalence of mouse and human marrow culture in the assay of CSF has been described earlier. Thus, mouse bone marrow formed colonies in response to human plasma, urine, or feeder layer prepared from human leukocytes, whereas human marrow formed colonies only in the presence of feeder layer (13) . More recently, Stanley (14) identified a subclass of CSF from murine L cell that stimulates the production of macrophages.
The biological significance of the existence of distinct types of CSF with different functions and specificities in vitro remains uncertain. A number of important and fundamental questions are raised by these observations. Why should a given CSF be more active in mouse than in human marrow or vice versa? What determines the type of colonies a given CSF stimulates? What is the relation of in vitro activity to what might be obtained in vivo? Detailed biochemical and immunological studies of highly purified preparations of these two types of CSF should provide the answers to some of these and other important questions. The availability of CSF-secreting permanent human cell lines such as MIA PaCa-2 should provide an excellent source ofCSF for these objectives. Thus far, type I CSF has been purified to homogeneity (9) and the purification of type II CSF is well in progress.
